Hasil Pencarian  ::  Simpan CSV :: Kembali

""Handbook of Dialysis is now completely revised in its Fifth Edition. It continues to provides practical, accessible information on all aspects of dialysis with emphasis on day-to-day patient management. Authored by international experts, chapters provide complete coverage of hemodialysis, peritoneal dialysis, special problems in dialysis patients, and problems pertaining to various organ systems"--Provided by publisher."

"Jumlah pasien gagal ginjal terminal di Indonesia terus meningkat. Peningkatan prevalensi hipertensi dan diabetes adalah salah satu kontributor peningkatan kasus penyakit gagal ginjal kronik. Meskipun Continuous Ambulatory Peritoneal Dialysis (CAPD) telah diperkenalkan sebagai terapi pengganti ginjal CAPD masih jarang digunakan dan hemodialisa masih merupakan tindakan mayoritas yang dipilih di Indonesia. Tujuan dari studi ini adalah untuk melakukan analisa efektivitas biaya antara HD dan CAPD. Penelitian membandingkan 78 pasien HD di RS PMI Bogor dan 10 pasien CAPD di RSUP Fatmawati Jakarta. Kualitas hidup pasien menggunakan kuisoner SF 36. Beban ekonomi untuk biaya langsung medis menggunakan tarif INA CBGs dan biaya lainnya menggunakan kuisoner beban ekonomi. Biaya total hemodialisa setahun adalah Rp 133.396.692,- dan Rp 81.680.000,- untuk CAPD. 46,2% pasien hemodialisa mempunyai kualitas hidup baik dan 90% pasien CAPD mempunyai kualitas hidup baik. Analisa Bivariat menunjukkan bahwa kualitas hidup pasien CAPD terbukti siknifikan pada aspek peran fisik, emosi, rasa nyeri, energi, fungsi sosial dan kesehatan jiwa. CAPD lebih cost efektif dibandingkan HD dengan nilai ICER adalah Rp 2.032.889,- untuk setiap ekstra peran emosi lebih baik dan Rp 1.780.265,- untuk setiap ekstra peran fisik lebih baik serta dominan untuk biaya dan kualitas hidup pada CE Plan.

---

Number of patients with End Stage Renal Disease (ESRD) in Indonesia is growing. The increased prevalence of hypertension and diabetes mellitus is a contributor to the increase in patients with CKD (Chronic Kidney Disease). Ever since Continuous Ambulatory Peritoneal Dialysis (CAPD) was intoduced as a form of renal replacement therapy, CAPD still small number of users and Haemodilysis still constitute the majority of renal replacement therapy in Indonesia. The aim of this study is to analize the cost effectiveness between HD and CAPD on ESRD patients. Study compared 78 HD patients at PMI Hospital in Bogor and 10 CAPD patients at Fatmawati Hospital in Jakarta. Patient quality of life interviewed by SF 36 questionnaire. Economic burden divided in two measurement. Direct medical cost measured by INA CBGs packet, direct non medical cost (transportation, food for patient and family) and indirect medical cost (opportunity cost) will be measure by economic burden questionnaire. Haemodialysis total cost per year is Rp 133.396.692,- and Rp 81.680.000,- for CAPD. 46,2% Haemodialysis patient has good quality of life and 90% for CAPD. Bivariat analysis showed Quality of life CAPD patient significant in phisical activities, emotional, pain, energy, sosial function and sanity. CAPD is cost effective compare to HD with ICER Rp 2.032.889,- for ekstra better emotional role and Rp 1.780.265,- for ekstra better phisical role and dominant for cost and quality of life at CE Plan

Key words: cost effectiveness analysis, Haemodialysis, CAPD"

"Pediatric dialysis, brings this knowledge together to provide the most comprehensive source of state-of-the-art information on the dialysis of infants, children and adolescents. With new chapters, updated chapters and references, and contemporary, unique perspectives from authors who are leaders in the global pediatric nephrology community, pediatric dialysis, an authoritative reference that will facilitate best practices in both acute and chronic dialysis. Experienced clinicians and trainees alike will find pediatric dialysis,not only another valuable contribution to the literature but an indispensable guide to managing their pediatric patients on dialysis."

"ABSTRACTThis study was carried out to ascertain the effect ofessential amino acids supplementation in renal failure patients ondialysis. 22 renal failure patients on dialysis without any signsand symptoms of G.I. disorders, liver disease, uncontrolleddiabetic mellitus were recruited to . the study. 11 patients servedas subjects and received essential amino acids supplementation, 11others served as control group who received placebo. The subjectshad undergone basic physical examination, biochemical assessment(Hb, transferrin, ureum and creatinine) and dietary assessment atthe beginning and at the end of the study. The study cone 1 udedthat the essential amino acids supplementation given to renalfailure patients on dialysis has significantly increased thetransferrin value, this may suggest an improvement of the proteinstatus of the patients. The study a 1 so pointed out that theincreased in transferrin as an effect of the essential amino acidssupplementation didt:l.'t cause an extra burden to the kidneys.Further investigations are needed to reconfirm this finding"